A genetic assay designed to predict breast cancer metastasis and response to adjuvant chemotherapy has undergone rapid uptake, and clinicians are gene... More »
A genetic assay designed to predict breast cancer metastasis and response to adjuvant chemotherapy has undergone rapid uptake, and clinicians are gene... More »
Palbociclib, a cyclin-dependent kinase 4/6 inhibitor, has been approved by the Food and Drug Administration for treating postmenopausal women with est... More »
Palbociclib, a cyclin-dependent kinase 4/6 inhibitor, has been approved by the Food and Drug Administration for treating postmenopausal women with est... More »
SAN ANTONIO – Though breast cancer survivors have a two- to sixfold higher risk of developing a second primary cancer compared with women in the gen... More »
SAN ANTONIO – Though breast cancer survivors have a two- to sixfold higher risk of developing a second primary cancer compared with women in the gen... More »
The ipsilateral local failure rate in women with good-risk ductal carcinoma in situ was low with observation after breast-conserving surgery, but was ... More »
The ipsilateral local failure rate in women with good-risk ductal carcinoma in situ was low with observation after breast-conserving surgery, but was ... More »
SAN ANTONIO – Male breast cancers share some important characteristics with female breast cancers: The tumors found in males are usually hormone receptor positive and of luminal A subtype, and...
SAN ANTONIO – Adding ovarian suppression to 5 years of tamoxifen in women with hormone receptor–positive early breast cancer who remain premenopausal following chemotherapy provides a markedly...